Jan. 14 at 5:47 PM
$GANX For those who know the biotech space well and how the JPM Healthcare conference works, would you say no announced deal is better than an announced deal?
Guessing that waiting to see what the durability data looks like in March would increase what Gain could ask for.
Until then, would it be fair to say Gain and potential buyers are discussing options based on what the data shows later, that way potential buyers could move fast after any readouts?
